Re-evaluating the suitability of using fluoroquinolones in the treatment of infections in the context of FQ consumption and correlating changes to microorganism resistance levels in EU/EEA countries between 2016 and 2021.
Journal Information
Full Title: Naunyn Schmiedebergs Arch Pharmacol
Abbreviation: Naunyn Schmiedebergs Arch Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethical approvalNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Author contributions: Piotr Serwacki and Jadwiga Wójkowska-Mach conceived the concept of the study and are corresponding authors. Piotr Serwacki, Mateusz Gajda and Jadwiga Wójkowska-Mach contributed to the design of the research. Mateusz Gajda contributed to the visualization of results. Piotr Serwacki, Mateusz Gajda, Wioletta Świątek-Kwapniewska, Marta Wałaszek, and Karolina Nowak were involved in data collection and analyzed the data. Jadwiga Wójkowska-Mach coordinated funding for the project. All authors edited and approved the final version of the manuscript. The authors declare that all data were generated in-house and that no paper mill was used."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025